TABLE 2

Comparison of clinical characteristics of RACED participants according to VADT treatment assignment

StandardIntensiveP
n159142
Age (years)61 ± 961 ± 90.89
NHW69620.23
Duration of diabetes (years)12.0 ± 7.712.2 ± 8.30.77
BMI (kg/m2)31.7 ± 4.331.3 ± 4.40.47
History of CVD39370.67
Current smoker15150.94
History of hypertension78810.49
SBP (mmHg)132 ± 18130 ± 160.32
DBP (mmHg)75 ± 1075 ± 110.72
A1C9.3 ± 1.49.3 ± 1.50.94
Total cholesterol (mmol/l)4.64 ± 0.964.67 ± 1.010.73
HDL cholesterol (mmol/l)0.92 ± 0.270.98 ± 0.260.03
LDL cholesterol (mmol/l)2.65 ± 0.792.77 ± 0.790.23
Triglycerides (mmol/l)2.48 ± 1.642.04 ± 1.240.01
Statin use57640.23
TZD use12100.56
ASA use86860.95
BP medication91890.61
  • Data are means ± SD or percent unless otherwise indicated. ASA, aspirin; BP, blood pressure; DBP, diastolic blood pressure; NHW, non-Hispanic white; SBP, systolic blood pressure; TZD, thiazolidinedione. P values are from independent-samples t tests or Wilcoxon or χ2 tests, as appropriate.